NexImmune, Inc. NEXI
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow NEXI
Growth Flags
show if company had growth for consecutive years
| Jun '24 | Mar '24 | Dec '23 | Sep '23 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
0.66 | 1.30 | 1.06 | 1.66 |
+8 more quarters Free account |
Net Debt/EBITDA |
0.71 | 1.69 | 0.63 | 0.88 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 3.45% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.06 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.89 | 0.79 | 1.09 | 0.74 | |
Capex/Depreciation |
0.58 | 4.55 | 0.00 | 0.01 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.47) | (1.51) | (5.56) | (6.95) | |
Cash per Share |
1.77 | 3.58 | 3.07 | 8.64 | |
Shareholders Equity per Share |
0.50 | 2.19 | 3.34 | 7.88 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.50 | 2.19 | 3.34 | 7.88 | |
Free Cash Flow |
(2.03) | (1.89) | (5.83) | (7.28) | |
Working Capital |
(1.61) | 1.41 | 0.32 | 4.12 | |
Capital Expenditures |
0.04 | 0.52 | 0.00 | 0.00 | |
Net Current Asset Value |
(2.04) | (0.21) | 0.32 | 4.01 | |
| Other line items | |||||
Quick Ratio |
0.52 | 0.97 | 0.63 | 1.46 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.50) | (1.93) | (5.56) | (6.95) | |
Capex per Share |
0.03 | 0.42 | 0.00 | 0.00 | |
Average Payables |
0.93 | 0.71 | 1.86 | 1.00 | |
Average Assets |
14.67 | 19.83 | 25.83 | 36.12 | |
Average Common Equity |
8.85 | 13.16 | 17.91 | 27.98 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates